Comments
Loading...

Akebia Therapeutics

AKBANASDAQ
Logo brought to you by Benzinga Data
$2.37
0.3014.49%
At close: -
$2.36
-0.01-0.43%
After Hours: 6:50 PM EDT

Akebia Therapeutics (NASDAQ:AKBA) Stock, Earnings Estimates, EPS, And Revenue

Akebia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 13
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$40.91M
Annual Revenue
(as of Sep 30)
$169.88M

Analyze the earnings history of Akebia Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Akebia Therapeutics (AKBA) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-07$-0.10$-0.06-66.7 %
Q22024-08-08$-0.04$-0.0520.0 %
Q12024-05-09$-0.09$-0.08-12.5 %
Q42024-03-14$0$-0.04100.0 %

Akebia Therapeutics (AKBA) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-07$37.43M$44.51M-15.9 %
Q22024-08-08$43.65M$49.45M-11.7 %
Q12024-05-09$32.61M$46.34M-29.6 %
Q42024-03-14$56.20M$55.39M1.46 %

FAQ

Q

When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?

A

Akebia Therapeutics (AKBA) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Akebia Therapeutics (NASDAQ:AKBA)?

A

The Actual EPS was $-0.10, which missed the estimate of $-0.06.

Q

What were Akebia Therapeutics’s (NASDAQ:AKBA) revenues?

A

The Actual Revenue was $37.4M, which missed the estimate of $44.5M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch